A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach

F. Lanza, F. Saraceni, A. Pezzi, M. Martino, A. Bosi, N. Cascavilla, P. Musto, E. Zuffa, M. Tani, C. Cellini, D. Laszlo, F. Bonifazi, on behalf of GITMO (Italian Society for Transplantation)

Research output: Contribution to journalArticlepeer-review

Cite this